SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

29 Jun 2016 07:00

RNS Number : 5697C
Rentokil Initial PLC
29 June 2016
 

29th June 2016

 

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Rentokil Initial plc (FTSE: RTO) today announces the appointment of Christopher (Chris) Geoghegan to its Board as a Non-Executive Director with effect from 28th June 2016. Chris will also become a member of the Remuneration Committee on his appointment to the Board.

 

Chris Geoghegan has extensive general management and commercial experience working in international markets, as well as broad non-executive experience in construction and support services. He had a long and distinguished executive career in the defence, electronics and aerospace industries. He was Group Executive Director, UK and Rest of the World and prior to that Joint Chief Operating Officer, BAE Systems plc from 2002 to 2007 where he was also a main board director. He also worked in a series of senior executive roles at Airbus and British Aerospace over a 34 year executive career. He has a wealth of experience of complex, international companies, operating with with large distributed workforces across Europe, Asia-Pacific and Africa. He is a Fellow of the Royal Aeronautical Society and past President of the Society of British Aerospace companies.

 

As previously announced, Peter Bamford, a member of the Audit Committee, retired after serving nine years on the Board, following Rentokil Initial's AGM earlier this year.

 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

 

"We are delighted to welcome Chris to the Board. He is a highly experienced and respected business leader who I am confident will bring valuable international business insight to the Board. We wish him well in his new role."

 

Chris Geoghegan has had the following directorships in publicly quoted companies during the previous five years:

 

Non-executive director, Kier Group plc 2007-14

Non-executive director, Volex plc 2008-13

Chairman, e2v Technologies plc 2009-13

Chairman, Hampson Industries plc 2007-11

Non-executive director, Lakehouse plc 2015-16

Non-executive director, SIG plc from 2009

 

In accordance with Listing Rule 9.6.15, it is confirmed that there are no details to be disclosed pursuant to Listing Rule 9.6.13.

 

Ends

 

 

Notes to Editors

 

About Rentokil Initial plc

 

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts.

 

www.rentokil-initial.com

 

 

 

 

Enquiries:

 

Investor / Analyst

Katharine Rycroft, Investor Relations Rentokil Initial plc 07811 270 734

 

Media

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Ben Woodford Bell Pottinger 0203 772 2549

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUQAQUPQPPR
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.